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1 Charité –Universitätsmedizin Berlin, Center for Stroke Research Berlin, Berlin, Germany, 2 Charité –
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To investigate the relationship between high FVIII clotting activity (FVIII:C), MRI-defined
white matter hyperintensities (WMH) and cognitive function over time.
Methods
Data from the population-based Cardiovascular Health Study (n = 5,888, aged�65) were
used. FVIII:C was measured in blood samples taken at baseline. WMH burden was
assessed on two cranial MRI scans taken roughly 5 years apart. Cognitive function was
assessed annually using the Modified Mini-Mental State Examination (3MSE) and Digit
Symbol Substitution Test (DSST). We used ordinal logistic regression models adjusted for
demographic and cardiovascular factors in cross-sectional and longitudinal WMH analyses,
and adjusted linear regression and linear mixed models in the analyses of cognitive
function.
Results
After adjustment for confounding, higher levels of FVIII:C were not strongly associated with
the burden of WMH on the initial MRI scan (OR>p75 = 1.20, 95% CI 0.99–1.45; N = 2,735)
nor with WMH burden worsening over time (OR>p75 = 1.18, 95% CI 0.87–1.59; N = 1,527).
High FVIII:C showed no strong association with cognitive scores cross-sectionally
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(3MSE>p75 β = -0.06, 95%CI -0.45 to 0.32, N = 4,005; DSST>p75 β = -0.69, 95%CI -1.52
to 0.13, N = 3,954) or over time (3MSE>p75 β = -0.07,95% CI -0.58 to 0.44, N = 2,764;
DSST>p75 β = -0.22, 95% CI -0.97 to 0.53, N = 2,306) after confounding adjustment.
Interpretation
The results from this cohort study of older adult participants indicate no strong relationships
between higher FVIII:C levels and WMH burden or cognitive function in cross-sectional and
longitudinal analyses.
Introduction
White matter hyperintensities (WMH) on MRI are common among older adults. According
to a Dutch community-based study, the prevalence of WMH in healthy volunteers aged
between 60 and 90 years was estimated to be 95%, and both prevalence and severity were
found to increase with age [1]. In addition to being associated with traditional cardiovascular
risk factors, changes in brain morphology, including WMH development, have been impli-
cated in cognitive decline, incident cognitive impairment, and the development of dementia
[2–6].
Coagulation factor FVIII (FVIII) levels generally increase with age [2]. Acute elevation of
FVIII is known to occur during the acute phase of stroke as part of the inflammatory response
[3]. A dose-dependent relationship between FVIII levels and the occurrence of thrombotic
events (including overt ischemic stroke) has also been observed [4–8]. Further studies have
linked FVIII, a potential therapeutic target, with dementia risk [9,10] as well as risk for cogni-
tive impairment in a study of men [11]. Previous research in the US-based Cardiovascular
Health Study (CHS) found an association between higher FVIII and incident cardiovascular
disease, stroke, and death in the older general study population [12], but these studies did not
investigate covert WMH or cognitive decline.
It remains unclear whether FVIII may contribute to the severity of covert WMH burden
and worsening over time. It is also unknown whether high FVIII levels contribute to cognitive
decline in this population, a process that may, in turn, be mediated by WMH. The present
study aims to probe these relationships to better understand the role of FVIII, if any, in the
pathways leading to cognitive decline in both cross-sectional and longitudinal settings, using
data from a large, population-based cohort.
Methods
Participants and design
In this cohort study, we used data from the Cardiovascular Health Study (CHS) in all analyses.
The design of the full longitudinal, population-based CHS, which aimed to assess risk factors
for cardiovascular disease is described in detail elsewhere [13]. Briefly, the original CHS cohort
included adults aged 65 and older recruited from four United States communities using Medi-
care eligibility lists. The first cohort of participants (N = 5,201) were enrolled in 1989 and
1990. A second cohort oversampling African-Americans (n = 687) was enrolled in 1992 and
1993; however, since FVIII levels were not measured in this group, the second cohort could
not be included in our analyses. As illustrated in Fig 1, participants were prospectively followed
for 9 years after the baseline visit and completed yearly clinic visits or phone interviews. An
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overview of all relevant variables used in our study and a timeline of their acquisition in the
CHS is shown in Fig 1.
Baseline assessment
The exposure variable of interest, FVIII clotting activity (FVIII:C), was measured in blood
samples of 5,112 participants taken at baseline. Clotting activity was assayed using the Coag-a-
mate X2 instrument with WHO standards, and activity units are expressed as percentages of
normal pooled plasma [14]. The mean coefficients of variation of two control pools were 9%
and 10%.
Other relevant variables measured at baseline included self-reported age, sex, and ethnicity.
Participants were also asked to provide information about their highest level of completed edu-
cation and information regarding smoking status and alcohol consumption. Smoking status
was categorized as never, former, or current. Alcohol consumption was classified as never,
occasionally, or frequently, which was defined as consuming more than 7 drinks per week, on
average.
We considered other measurements taken at the baseline clinic visits as markers for cardio-
vascular risk. Participants’ measured weight (kg) and squared height (m2) were used to com-
pute body mass index (BMI). Individuals presenting with�140 mmHg (systolic) or�90
mmHg (diastolic) seated blood pressure at baseline were classified as ‘hypertensive’ in addition
to those who both reported a history of hypertension and were taking antihypertensive medi-
cation at baseline. High density lipoprotein cholesterol (HDL, mg/dL) and adjusted low-den-
sity lipoprotein cholesterol, (LDL, mg/dL) were measured from blood samples and recorded as
continuous variables. Furthermore, participants’ fasting plasma glucose levels were used to
determine diabetes status according to current American Diabetes Association guidelines as
‘normal’(<100mg/dL), ‘impaired fasting glucose’ (100-125mg/dL), or ‘diabetic’ (�126 or
reported taking insulin or oral hypoglycemics). Maximum common carotid intima-media
thickness (CIMT) and maximum internal CIMT were defined as the mean of maximum wall
thickness measurements made during all scans using ultrasonography used as indicators of
carotid atherosclerosis [15]. Further relevant blood biomarker measurements included C reac-
tive protein (CRP, mg/L) and fibrinogen (mg/dL). In addition to information on whether the
participant had a history of stroke or transient ischemic attack (TIA) at baseline, incident
stroke or incident TIA events occurring during CHS follow-up were also recorded [16].
Ascertainment of outcomes
Cranial MRI scans were performed in two waves over several years. The initial scan occurred
during the 2nd through 4th follow-up visits (1991–1994), and the follow-up scan during the
Fig 1. Timeline of CHS data collection. Measurements collected at baseline and at each follow-up are listed per year. Abbreviations: FU, follow-up; FVIII:C,
coagulation factor VIII activity; 3MSE, Modified Mini-Mental State Examination; DSST, Digit Symbol Substitution Test; MRI, magnetic resonance imaging, TICS,
Telephone Interview for Cognitive Status.
https://doi.org/10.1371/journal.pone.0242062.g001
PLOS ONE Coagulation factor VIII, white matter hyperintensities and cognitive function in the CHS
PLOS ONE | https://doi.org/10.1371/journal.pone.0242062 November 16, 2020 3 / 15
8th and 9th follow-up visits (1997–1999), allowing for the assessment of changes in brain mor-
phology in CHS participants over an average time interval of 5 years [17,18]. Areas of hyperin-
tensities in the periventricular and subcortical regions as observed on standardized sagittal
axial-spin density/T2-weighted cranial MRI images were used to quantify WMH burden, one
of our outcomes of interest [19]. The WMH burden apparent on each scan was evaluated by
experienced neuroradiologists at a central CHS Reading Center using a 10-point white matter
grade (WMG) scale, ranging from 0 (no lesions) to 9 (most lesions) based on a library of tem-
plates [18]. In additional, the initial and follow-up MRI scans were read side-by-side to deter-
mine any worsening of the WMG between the two scans [17].
Cognitive ability was measured using multiple assessment tools. The first, the 100-point Modi-
fied Mini-Mental State Examination (3MSE) [20], was introduced during the first follow-up wave
(1990–91) and administered annually thereafter during in-person clinic visits. Missing 3MSE
scores could be estimated from the Telephone Interview for Cognitive Status (TICS) scores, when
these data were available. TICS were first introduced during the sixth follow-up (1995–96), and
these estimates have previously been confirmed to be reliable substitutions for 3MSE scores [21].
To provide an indication of the robustness of our results, we included an additional assess-
ment of cognitive function as a second outcome: the Digit Symbol Substitution Test (DSST).
This timed, 90-second test measures both attention and processing speed. The DSST over-
comes the known challenge of the ceiling effect of the 3MSE [22]. The DSST was administered
at baseline (1989–90) and annually thereafter during in-person clinic visits. For consistency
between the two outcome measures, we considered only 3MSE scores (or the imputed TICS
estimates thereof) and DSST scores measured during the 1st through 9th follow-up visits as
continuous outcomes in our longitudinal analyses.
Inclusion/Exclusion criteria
In addition to the general inclusion and exclusion criteria of the CHS [13], we additionally
excluded from our analyses all participants with missing FVIII:C measurements or with a his-
tory of one or more of the following at baseline: clinical stroke, TIA, prevalent dementia, and/
or low cognitive function. Low cognitive function was defined as scoring less than 78 on the
first 3MSE measurement, an established cutoff used in other CHS cognition studies [23], or in
the lowest 10% of all scores on the first included DSST. Prevalent dementia and cognitive func-
tion (as measured by 3MSE) were first assessed in 1990–91.
Statistical analyses FVIII:C categorization
For our primary analyses, participants were categorized according to their FVIII activity levels
(FVIII:C). High (>75th percentile) and low (�25th percentile) FVIII:C levels were compared to
the middle reference interval between the 25th and 75th percentiles, based on our a priori analy-
sis plan. In secondary analyses, FVIII:C were analyzed continuously as normalized variables by
dividing FVIII:C by the standard deviation (SD) of all FVIII:C measurements. To explore possi-
ble dose response, we used quintiles to group FVIII:C using the middle fifth as a reference. As a
sensitivity analysis to assess robustness of our findings, we performed an additional categoriza-
tion of FVIII:C. High (>90th percentile) and low (�10th percentile) FVIII:C levels were com-
pared to participants with FVIII:C in the 10th– 90th percentile interval (reference).
White matter hyperintensity burden at initial cranial MRI scan: Cross-
sectional analyses
Cross-sectional analyses were conducted to determine whether FVIII:C levels were associated
with WMH burden on the initial MRI scan (see Fig 1) in all participants having initial scan
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results. For this analysis, the outcome variable, WMH burden, was grouped by grade into
three groups (0–1, 2–3, 4–9). Differences in mean FVIII:C between WMG groups were
assessed using an ANOVA.
We then used ordinal logistic regression to probe the relationship between FVIII:C and
WMH burden using the gologit2 command in Stata, which can relax the proportional odds
assumption as needed for specific explanatory variables (this is known as fitting a partial pro-
portional odds model) [24,25]. In addition to an unadjusted model (model 1), we provide two
additional models conditioning for potential confounding variables: model 2: adjusted for a
priori selected demographic and socioeconomic factors including age, sex, ethnicity, and edu-
cation level; and model 3: additionally adjusting for a priori selected lifestyle and cardiovascu-
lar risk factors: smoking, alcohol use, BMI, hypertension, diabetes, HDL and LDL cholesterol,
fibrinogen, CRP, maximum common and internal CIMT, and the occurrence of a TIA or
stroke event during the follow-up period prior to the initial MRI scan, as defined previously.
Logarithmic transformations were used for variables with right-skewed distributions including
both CIMT measurements and CRP. Since incident TIA or stroke events could be mediators
for the exposure-outcome relationship, we conducted an additional sensitivity analysis in
which this variable was omitted. We report ordinal odds ratios with corresponding 95% confi-
dence intervals (95% CI) for each model.
Worsening of white matter grade between MRI scans: Longitudinal
analyses
We report odds ratios with corresponding 95% CI from ordinal logistic regression models to
quantify the worsening in WMG between the two MRI scans taken on average 5 years apart.
Thus, only participants who underwent both MRI scans were included in these analyses.
Change between scans was a priori categorized as no worsening in WMG, a worsening of 1
grade, or a worsening of 2 or more grades. The analyses were additionally adjusted for the
elapsed time between participants’ initial and follow-up MRI scans but not for baseline WML
grade, as WML grade changes were likely to precede our baseline assessment and such adjust-
ment is thus likely to introduce bias [26].
FVIII:C and cognitive function: Cross-sectional and longitudinal analyses
We used linear regression models to obtain estimates of the effect of baseline FVIII:C (β and
95% CIs) on 3MSE scores measured at the first follow-up in three adjusted models as described
above. We then used linear mixed models with random intercepts for each individual to inves-
tigate the relationship between FVIII:C and cognitive function over time, as measured by serial
3MSE scores. These models handle missing data and the dependent nature of the repeated
measurements within individuals. As a secondary analysis, we repeated both cross-sectional
and longitudinal analyses using DSST scores instead of 3MSE. Effect estimates and 95% CIs
are reported for the 3 models, as well as the model variance between individuals.
Standard protocol approvals, registrations and patient consents
Informed written consent was obtained from all CHS participants at entry into the study and
at periodic intervals during follow-up. Institutional review boards at each CHS center
approved the study. The IRB at the Charité - Universitätsmedizin Berlin also approved this sec-
ondary data analysis, and data was transferred in a fully anonymized form for analysis.
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Results
Description of study population
After applying our inclusion and exclusion criteria as shown in the participant flowchart (Fig
2), our study population consisted of 4,295 participants whose characteristics are summarized
in Table 1. The study participants had a mean age of 72.3 years, 59.3% were female, and 96.0%
were white. In total, 45.5% of included participants were hypertensive and 13.9% were
diabetic.
FVIII:C and white matter grade
Of the 2,735 participants who underwent the first MRI scan, mean FVIII:C differed among
WMG groups (p = 0.001). Participants with the highest burden of WMH on this scan (grades
4–9) had higher mean FVIII:C (121.2) than participants with WMG of 2–3 (120.5) or WMG
0–1 (115.3) (see Table 2). Ordinal analyses using three groups of WMG (0–1, 2–3, and 4–9)
revealed a weak association between high FVIII:C (>p75)–compared to normal levels–and
WMG (model 3 OR = 1.20, 95% CI 0.99–1.45) in participants with initial MRI scan results
(Table 2). Furthermore, each increase in FVIII:C by one standard deviation (36 units) was not
associated with substantially worse WMG at the initial MRI scan after full adjustment (model
3 OR = 1.08, 95% CI 0.99–1.17).
We report results from longitudinal analyses in Table 3. Considering worsening of WMG
between the two scans, after full adjustment for potential confounding factors, the ordinal
logistic regression analysis revealed no meaningful association between high FVIII:C (>p75)
and the degree of worsening over the time period between scans (model 3 OR = 1.18, 95% CI
0.87–1.59).
Similar findings were observed in secondary analyses considering per SD increase in FVIII:
C as the exposure (model 3 OR = 1.07, 95% CI 0.94–1.22).
FVIII:C and cognitive function
Table 4 shows results from cross-sectional analyses using 3MSE (n = 4,005) and DSST
(n = 3,954) scores from study year 1991–92 (first follow-up) as outcomes. Though a small asso-
ciation between high FVIII:C (>p75) and lower 3MSE scores was observed in the crude linear
regression model (β1 = -0.55; 95% CI -0.95 to -0.15), this association disappeared after full con-
founding adjustment (β3 = -0.06, 95% CI -0.45 to 0.32). The unadjusted association with DSST
score (β1 = -2.05, 95% CI -2.94 to -1.16), was also greatly reduced after full adjustment (β3 =
-0.69, 95% CI -1.52 to 0.13). For the DSST scores, we observed a slight dose response in the
crude quintile assessment. Per SD of FVIII:C, we also found no association between high
FVIII:C and lower 3MSE or DSST scores in the fully adjusted models (Table 4).
Linear mixed-effects regression with random intercepts was then used to investigate
whether FVIII:C measured at baseline were associated with cognitive ability over time
(Table 5). The numbers of participants with available measurements in the final year of follow-
up were N = 2,764 (3MSE or TICS estimate) and N = 2,306 (DSST). As was observed in the
cross-sectional setting, having high (>p75) FVIII:C was not associated with 3MSE over the
course of study follow-up in the fully adjusted models (β3 = -0.07, 95% CI -0.58 to 0.44; β3 per
SD of FVIII:C = 0.15, 95% CI -0.06 to 0.37). Furthermore, no clinically relevant association
was observed between high FVIII:C and change in DSST score over time, after adjustment (β3
= -0.22, 95% CI -0.97 to 0.53; β3 per SD of FVIII:C = -0.11, 95% CI -0.43 to 0.22).
As a sensitivity analysis, we repeated the above analyses with p10/p90 cutoffs, which did not
substantially alter the results. Furthermore, omitting the variable ‘occurrence of a TIA or
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stroke event during the follow-up’ from the third model (as it may be both an intermediate
and confounder) resulted in nearly identical point estimates.
Discussion
In the present study, we estimated the effects of FVIII:C on WMH burden and cognitive func-
tion both cross-sectionally and over time in a population-based sample of older persons in the
CHS. Although participants with high WMG on the first MRI scan had higher mean FVIII:C
Fig 2. Study inclusion flow chart. Dementia was first adjudicated in 1990–91. DSST and 3MSE scores from that study
year were also used to determine participant inclusion for this study. Abbreviations: FVIII:C, coagulation factor VIII
activity; FU, follow-up; 3MSE, Modified Mini-Mental State Examination; DSST, Digit Symbol Substitution Test; MRI,
magnetic resonance imaging; TICS, Telephone Interview for Cognitive Status; TIA, transient ischemic attack.
https://doi.org/10.1371/journal.pone.0242062.g002
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than participants with no or low WMG, no strong association was observed between high
FVIII:C and WMH burden in the cross-sectional analyses. Furthermore, high FVIII:C did not
appear to be linked to worsening of the WMG between MRI scans performed about 5 years
apart after adjustment for confounding variables.
Table 1. Baseline characteristics of study population.
Characteristic (n = 4,295)
Mean age (SD), years 72.3 (± 5.3)
Female sex, N (%) 2,549 (59.3%)
White, N (%) 4,124 (96.0%)
Education, N (%)a
< Grade 12 986 (23.0%)
Completed high school/GED 1,296 (30.2%)
Vocational or some college 1,045 (24.3%)
Graduate degree/professional 960 (22.4%)
BMI (SD), kg/m2 26.4 (± 4.5)
Hypertension, N (%) 1,950 (45.4%)
Cholesterol (SD), mg/dL
Total 212.3 (± 39.0)
HDL 54.4 (± 15.9)
LDL 130.4 (± 35.4)
Diabetes, N (%)
None 3,101 (72.2%)
Impaired fasting glucose 592 (13.8%)









FVIII:C (IQR), %b 116 (95–141)
CRP (IQR), mg/L 2.4 (1.2–4.2)
Fibrinogen (IQR), mg/dL 311 (270.0–361)
Max Common CIMT (IQR), mm 0.96 (0.86–1.08)
Max Internal CIMT (IQR), mm 1.33 (0.90–1.90)
3MSE score (IQR)c 94 (89–97)
DSST score (IQR)d 42 (35–51)
Abbreviations: GED = General Educational Development (high school equivalency diploma); BMI = body mass
index; HDL = high-density lipoprotein; LDL = low-density lipoprotein; FVIII:C = coagulation factor VIII activity;
CRP = C-reactive protein; CIMT = carotid intima-media thickness; 3MSE = Modified Mini-Mental State
examination; DSST = Digit Symbol Substitution Test; IQR = interquartile range.
a Owing to missing data, percentages may not total 100. All variables have <2% missing values except 3MSE (6.8%),
and DSST (7.9%).
b percentage of normal pooled plasma
c out of 100 possible points, measured during 1991–92 study year
d out of 90 possible points, measured during 1991–92 study year
https://doi.org/10.1371/journal.pone.0242062.t001
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We additionally investigated the relationship between high FVIII:C and cognitive ability as
measured by two different scores. Although crude analyses showed an association, no mean-
ingful influence of high FVIII:C on 3MSE scores was observed in cross-sectional analyses after
adjusting for potential sources of confounding [27–30]. FVIII:C showed a small association
with DSST scores after full adjustment; on average, low FVIII:C (�p25) levels were associated
with scores 0.85 points higher (95%CI 0.06 to 1.64) and high levels (>p75) were associated
with scores 0.69 points lower (95%CI -1.52 to 0.13) than the reference group (p25-p75). A
dose response was observed across FVIII:C quintile groups and DSST scores in crude models,
though the effect sizes attenuated with adjustment. No meaningful relationship was observed
Table 2. FVIII:C and burden of white matter hyperintensities on initial cranial MRI scan (cross-sectional).
WMG 0–1 (n = 995) WMG 2–3 (n = 1,371) WMG 4–9 (n = 369) OR1b 95% CI OR2c 95% CI OR3d 95% CI
FVIII:Ca groups
� p25 285 337 97 1.06 (0.89–1.26) 1.03 (0.86–1.23) 1.03 (0.85–1.23)
p25-p75 522 690 182 1 ref 1 ref 1 ref
> p75 188 344 90 1.37 (1.11–1.68) 1.22 (1.02–1.46) 1.20 (0.99–1.45)
Continuous
per SD increase of FVIII:Ce 1.15 (1.07–1.24) 1.09 (1.01–1.17) 1.08 (0.99–1.17)
Abbreviations: FVIII:C = coagulation factor VIII activity; WMG = white matter grade; MRI = magnetic resonance imaging; OR = odds ratio; CI = confidence interval;
p25 = 25th-percentile; p75 = 75th-percentile; ref = reference category; SD = standard deviation
a percentage of normal pooled plasma
b unadjusted model
c model adjusted for demographic risk factors (age, gender, ethnicity, education level)
d model additionally adjusted for cardiovascular risk factors (hypertension, smoking status, diabetes, alcohol use, BMI, HDL cholesterol, LDL cholesterol, fibrinogen,
log-transformed C-reactive protein, log-transformed maximum common carotid intima-media thickness, log-transformed maximum internal carotid intima-media
thickness, and occurrence of stroke or TIA prior to initial MRI scan)
e one standard deviation increase in FVIII:C corresponds to 36 units
https://doi.org/10.1371/journal.pone.0242062.t002
Table 3. FVIII:C and white matter hyperintensity grade worsening on MRI scans over 5 years; results from ordinal logistic regression models.
No change (n = 1,098) 1 grade worse (n = 367) 2+ grades worse (n = 62) OR1b 95% CI OR2c 95% CI OR3d 95% CI
FVIII:Ca groups






p25-p75 552 185 25 1 ref 1 ref 1 ref















Abbreviations: FVIII:C = coagulation factor VIII activity; WMG = white matter grade; MRI = magnetic resonance imaging; OR = odds ratio; CI = confidence interval;
p25 = 25th-percentile; p75 = 75th-percentile; ref = reference category; SD = standard deviation
a percentage of normal pooled plasma
b model adjusted for time interval (in years) between MRI scans
c model additionally adjusted for demographic risk factors (age, gender, ethnicity, education level)
d model additionally adjusted for cardiovascular risk factors (hypertension, smoking status, diabetes, alcohol use, BMI, HDL cholesterol, LDL cholesterol, fibrinogen,
log-transformed C-reactive protein, log-transformed maximum common carotid intima-media thickness, log-transformed maximum internal carotid intima-media
thickness, and occurrence of stroke or TIA during follow-up period before second MRI scan
e one standard deviation increase in FVIII:C corresponds to 36.3 units
https://doi.org/10.1371/journal.pone.0242062.t003
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between high FVIII:C at baseline and cognitive worsening over time as measured by the 3MSE
or DSST after full confounding adjustment.
Although the relationship between WMH and cognitive outcomes is well described in the
literature [2–6], few studies have investigated the potential relationship between FVIII:C levels
and WMH. An earlier CHS paper with exploratory aims included FVIII:C as one of 70 poten-
tial predictors for WMH worsening [22]. However, these exploratory analyses were distinct
from the goals and corresponding approaches in our paper, as we aimed to obtain a confound-
ing-adjusted estimates of the specific effect of FVIII:C on WMG as well as FVIII:C on cognitive
Table 4. FVIII:C and cognitive test scores: Cross-sectional results using linear regression.
3MSE scores (100 points maximum), study year 1991–92 (n = 4,005)
β1 b 95% CI β2 c 95% CI β3 d 95% CI
FVIII:Ca percentile groups
� p25 0.61 (0.22 to 1.00) 0.33 (-0.03 to 0.69) 0.33 (-0.04 to 0.71)
p25-p75 0 ref 0 ref 0 ref
> p75 -0.55 (-0.95 to -0.15) -0.16 (-0.53 to 0.21) -0.06 (-0.45 to 0.32)
Continuous
per SD increase of FVIII:Ce -0.40 (-0.56 to -0.23) -0.16 (-0.31 to -0.01) -0.14 (-0.30 to 0.03)
FVIII:C quintile groups
Q1 (low) 0.22 (-0.24 to 0.68) 0.22 (-0.24 to 0.68) 0.22 (-0.25 to 0.69)
Q2 -0.24 (-0.70 to 0.22) -0.24 (-0.70 to 0.22) -0.25 (-0.72 to 0.22)
Q3 0 ref 0 ref 0 ref
Q4 -0.39 (-0.86 to 0.07) -0.39 (-0.86 to 0.07) -0.34 (-0.82 to 0.13)
Q5 (high) -0.28 (-0.75 to 0.19) -0.28 (-0.75 to 0.19) -0.18 (-0.67 to 0.31)
DSST scores (90 points maximum), study year 1991–92 (n = 3,954)
β1 95% CI β2 95% CI β3 95% CI
FVIII:C percentile groups
� p25 1.58 (0.71 to 2.44) 0.90 (0.13 to 1.68) 0.85 (0.06 to 1.64)
p25-p75 0 ref 0 ref 0 ref
> p75 -2.05 (-2.94 to -1.16) -1.01 (-1.81 to -0.22) -0.69 (-1.52 to 0.13)
Continuous
per SD increase of FVIII:Ce -1.16 (-1.53 to -0.80) -0.54 (-0.87 to -0.21) -0.37 (-0.72 to -0.02)
FVIII:C quintile groups
Q1 (low) 1.37 (0.26 to 2.48) 0.66 (-0.33 to 1.65) 0.53 (-0.48 to 1.53)
Q2 0.86 (-0.26 to 1.97) 0.57 (-0.43 to 1.56) 0.47 (-0.54 to 1.47)
Q3 0 ref 0 ref 0 ref
Q4 -0.86 (-1.99 to 0.27) -0.21 (-1.21 to 0.80) -0.12 (-1.14 to 0.89)
Q5 (high) -1.84 (-2.98 to -0.70) -0.80 (-1.81 to 0.22) -0.42 (-1.46 to 0.63)
Abbreviations: FVIII:C = coagulation factor VIII activity; 3MSE = Modified mini-mental state examination; DSST = Digit Symbol Substitution Test; CI = confidence
interval; p25 = 25th-percentile; p75 = 75th-percentile; ref = reference category; SD = standard deviation.
β coefficients were calculated using linear regression in three models.
a percentage of normal pooled plasma
b unadjusted model
c model adjusted for demographic risk factors (age, gender, ethnicity, education level)
d model additionally adjusted for cardiovascular risk factors (hypertension, smoking status, diabetes, alcohol use, BMI, HDL cholesterol, LDL cholesterol, fibrinogen,
log-transformed C-reactive protein, log-transformed maximum common carotid intima-media thickness, and log-transformed maximum internal carotid intima-media
thickness).
e one standard deviation increase in FVIII:C corresponds to 36.3 units
https://doi.org/10.1371/journal.pone.0242062.t004
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function. In the present study, potential sources of confounding were selected a priori, and the
methodology was not dependent on the combined explained variance of a regression model.
Although not in line with our original hypotheses, these results do align with some findings
from previous publications. For example, results from the ARIC study indicated that FVIII
might have another role in brain morphology that is not specifically related to white matter
lesion development; for instance, multiple midlife systemic inflammatory markers (including
FVIII) were associated with brain volume late in life [31]. Another recent publication from the
same cohort examined the relationship between an “inflammation composite score” that
included factor VIII in middle-aged individuals and 20-year cognitive decline [32]. The
authors found that each SD increase in the score was associated with additional decline, and
that the highest scores were associated with steeper declines over the 20-year period [32].
Taken together, it is feasible that FVIII exerts an effect over a longer period than we captured
in our study on cognitive function and by other pathways than via WMH development.
Results from the REGARDS study showed an association between high FVIII levels and
cognitive impairment in crude analyses, which were attenuated after multivariable adjustment,
similar to our findings [33,34]. These findings may indicate that high FVIII is a marker of one
or more underlying processes that play a causal role in cognitive impairment with increasing
Table 5. FVIII:C and cognitive test scores: Longitudinal results using linear mixed-effects regression.
3MSE scores (100 points maximum)
β1
b 95% CI β2
c 95% CI β3
d 95% CI
FVIII:Ca percentile groups
� p25 0.29 (-0.25 to 0.83) -0.27 (-0.76 to 0.21) -0.40 (-0.89 to 0.09)
p25-p75 0 ref 0 ref 0 ref
> p75 -1.09 (-1.64 to -0.54) -0.34 (-0.83 to 0.15) -0.07 (-0.58 to 0.44)
Model variance e 46.7 (44.4 to 49.1) 35.7 (33.9 to 37.6) 34.9 (33.1 to 36.8)
Continuous
per SD increase of FVIII:Cf -0.51 (-0.73 to -0.28) -0.02 (-0.22 to 0.19) 0.15 (-0.06 to 0.37)
DSST scores (90 points maximum)
β1 95% CI β2 95% CI β3 95% CI
FVIII:C percentile groups
� p25 1.33 (0.49 to 2.17) 0.50 (-0.21 to 1.21) 0.40 (-0.32 to 1.13)
p25-p75 0 ref 0 ref 0 ref
> p75 -1.87 (-2.73 to -1.01) -0.69 (-1.42 to 0.04) -0.22 (-0.97 to 0.53)
Model variance 119.5 (114.1 to 125.1) 83.4 (79.5 to 87.4) 80.3 (76.5 to 84.3)
Continuous
per SD increase of FVIII:C -1.11 (-1.46 to -0.76) -0.37 (-0.67 to -0.06) -0.11 (-0.43 to 0.22)
Abbreviations: FVIII:C = coagulation factor VIII activity; 3MSE = Modified mini-mental state examination; DSST = Digit Symbol Substitution Test; CI = confidence
interval; p25 = 25th-percentile; p75 = 75th-percentile; ref = reference category; SD = standard deviation.
β coefficients were calculated using linear mixed-effects regression with random intercepts in three models.
a percentage of normal pooled plasma
b unadjusted model
c model adjusted for demographic risk factors (age, gender, ethnicity, education level)
d model additionally adjusted for cardiovascular risk factors (hypertension, smoking status, diabetes, alcohol use, BMI, HDL cholesterol, LDL cholesterol, fibrinogen,
log-transformed C-reactive protein, log-transformed maximum common carotid intima-media thickness, log-transformed maximum internal carotid intima-media
thickness, and the occurrence of stroke or TIA during follow-up).
e variance between individuals for each model for the primary exposure categorization (percentile groups)
f one standard deviation increase in FVIII:C corresponds to 36.3 units
https://doi.org/10.1371/journal.pone.0242062.t005
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age, but is perhaps itself not a cause. Although our study did not investigate dementia diagno-
sis as an outcome, an earlier prospective study of middle-aged men found an association
between factor VIII levels and other coagulation markers on vascular dementia after 17 years
of follow-up (HR, 1.79; 95% CI, 1.09–3.00) [11]. More recently, a systematic review and meta-
analysis synthesized findings from 32 identified studies on the role of the hemostatic system
(including some coagulation factors) in cognitive decline in older persons. Among individuals
with vascular dementia, higher levels of FVIII were observed together with other coagulation
factors [35].
Study strengths and limitations
Strengths of this study include its population-based, prospective design, large number of older
participants, and multiple outcomes and time points of their assessment. Information about
many potential sources of confounding was collected and very few values were missing at base-
line (<2% of all potential confounding variables). Furthermore, starting with the sixth follow-
up, telephone-based estimates could be used to estimate missing 3MSE scores when in-person
visits were not possible.
While we were able to control for confounding by including a larger number of sociodemo-
graphic and cardiovascular risk factors, we acknowledge that some residual confounding may
still be present. However, adjusting for well-known, potentially strong sources of confounding,
such as age, did not change our results materially, suggesting that confounding due to weaker
unmeasured sources would not have substantially altered our results. It is also possible that
Model 3 resulted in some overadjustment, as the occurrence of a stroke or TIA during follow-
up could be both a source of time-dependent confounding and an intermediate on the causal
path.
Our sensitivity analysis revealed only small differences in the point estimates when this var-
iable was removed from the model, which would not change our interpretation of the results.
Readers should also consider some limitations with respect to the FVIII:C measurements
when interpreting our findings. In addition to its implication in thrombosis, FVIII is also a
known marker of relevant biological mechanisms such as inflammation and is an acute phase
reactant. Though the measurements in the CHS were taken when participants were healthy at
baseline, subclinical disease cannot be ruled out. The laboratory measurements of FVIII:C
were somewhat variable in the CHS study (coefficients of variation 9% and 10%), however, we
do not anticipate this variability in the laboratory measurements had any meaningful impact
on our results with such a large sample size. Furthermore, in this secondary data analysis, only
one FVIII:C measurement (taken at baseline) was available. When possible, future studies on
this topic should consider repeating these measurements to better understand how changes in
FVIII:C over time may impact WML and cognitive test performance in the healthy general
population.
With respect to our outcome assessments, given the non-linear nature of the WML grading
scale, we chose a priori to perform ordinal analyses to use all ordered information captured by
WMG. However, due to small group size in some WMG categories, which was anticipated
among the older general population, we collapsed the higher categories, thereby reducing the
resolution of the data. Furthermore, for the longitudinal analyses of worsening WMG, only
survivors remaining in the study through the eighth follow-up could be included due to the
need for the follow-up MRI, a selection that inherently leads to selection bias. As shown previ-
ously, participants who underwent at least one MRI scan were healthier than those who were
never scanned, and those with both the initial and follow-up scans were healthier than those
who only had the initial MRI scan [17], however, this is a limitation common to all studies
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involving MRI, and part of our motivation to also look at cognitive function measures. Future
studies with more frequent scans over a longer time period may provide valuable insights,
however, feasibility of such studies is remains a large obstacle.
We emphasize that these findings from an older, general population cohort should not be
extrapolated to younger individuals or specific chronically ill populations. We also cannot rule
out that the weak cross-sectional associations observed between FVIII:C and WMG may be
explained by reverse causation. WML, as an inflammatory stimulus, could also be a contribut-
ing cause of higher FVIII:C levels.
With regard to the cognition outcomes, we acknowledge that the true relationship between
high FVIII:C and 3MSE scores in both cross-sectional and longitudinal analyses may be stron-
ger than what we observed due to the ceiling effect of the 3MSE and the high number of partic-
ipants with high scores. However, upon comparing these results with a second measurement
of cognitive function, the DSST (without a ceiling effect), we observed no material differences.
We did not adjust any of our longitudinal models for baseline cognitive test scores, as this pro-
cedure introduces bias under some circumstances [26]. It is well known that individuals with
lower cognitive function are less likely to remain in studies, therefore, attrition was likely dif-
ferential with regard to the outcomes in the analyses using cognitive test scores. Therefore, the
cognitive decline of study participants is likely greater than what we observed in the partici-
pants who remained in the study. Although we had two measures of cognitive function, we
further acknowledge that neither assesses any one cognitive domain in depth, and readers
should interpret our results with this limitation in mind.
Conclusions
Our findings from this large, population-based study indicate no strong relationship between
FVIII:C and WMH burden or WMH worsening over time in the older general population fol-
lowing adjustment for demographic and cardiovascular factors. Furthermore, FVIII:C levels
do not appear to be associated with cognitive worsening, as measured using serial 3MSE and
DSST assessments. Though an important player in hemostatic balance and implicated in overt
vascular disease, this study suggests that FVIII:C is not strongly related to covert, subclinical
brain lesion development, and subsequent cognitive decline in older adults.
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